Your session is about to expire
← Back to Search
Culturally-appropriate social marketing campaign for Coronavirus
N/A
Waitlist Available
Led By Jennifer C Erves, PhD
Research Sponsored by Meharry Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
African American
Unvaccinated for COVID-19
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial is testing a social marketing intervention to increase confidence in the COVID-19 vaccine among African Americans in Nashville/Davidson County, Tennessee. The study's novelty lies in being the first to assess feasibility and preliminary efficacy of a multi-layered, culturally-appropriate social marketing intervention to promote COVID-19 vaccination among African Americans in TN.
Eligible Conditions
- Coronavirus
- Vaccine Refusal
- Communication
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Recruitment rates
Retention rates
data collection processes
Secondary outcome measures
Attitudes toward COVID-19 vaccine
COVID-19 vaccine rates
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Culturally-appropriate social marketing campaignExperimental Treatment1 Intervention
Participants will receive a multi-layered, social marketing campaign which is deemed culturally appropriate. This will occur over a 6 month -time period. Rates will be observed at 0, 6, and 12 months.
Group II: Control Arm 1Active Control1 Intervention
Participants will receive no intervention, only to serve as a control site. Rates will be observed at 0, 6, and 12 months.
Group III: Control Arm 2Active Control1 Intervention
Participants will receive no intervention, only to serve as a control site. Rates will be observed at 0, 6, and 12 months.
Find a Location
Who is running the clinical trial?
Meharry Medical CollegeLead Sponsor
18 Previous Clinical Trials
5,684 Total Patients Enrolled
St. Jude Children's Research HospitalOTHER
426 Previous Clinical Trials
5,306,305 Total Patients Enrolled
Jennifer C Erves, PhDPrincipal InvestigatorMeharry Medical College
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger